Catheter Precision closed a private placement of 2,821 shares of Series C-4 Convertible Preferred Stock for gross proceeds of $2.82 million.
- The securities carry a stated value of $1,000 per share; the closing occurred on July 30, 2026.
- Net proceeds are earmarked for working capital, general corporate purposes, and redemption of all outstanding Series B Convertible Preferred Stock.
- Dawson James Securities acted as placement agent; the sale relied on Section 4(a)(2) and Rule 506(b) exemptions.
- Series C-4 Preferred ranks senior to common stock; conversion into common stock would dilute existing holders.
VTAK•
